3000 ORAL Randomised phase III study of capecitabine, oxaliplatin and bevacizumab (CAPOX-B) with or without cetuximab in advanced colorectal cancer (ACC), the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim safety analysis
Tol, J, Koopman, M, Rodenburg, C.J, Cats, A, Creemers, G.J, de Swart, C.A.M, Erdkamp, F.L.G, Mol, L, Antonini, N.F, Punt, C.J.A
Published in European journal of cancer supplements (2007)
Published in European journal of cancer supplements (2007)
Get full text
Journal Article
A randomized phase II study of paclitaxel with carboplatin ± amifostine as first line treatment in advanced ovarian carcinoma
De Vos, F.Y.F.L, Bos, A.M.E., Schaapveld, M., de Swart, C.A.M., de Graaf, H., van der Zee, A.G.J., Boezen, H.M., de Vries, E.G.E., Willemse, P.H.B.
Published in Gynecologic oncology (01.04.2005)
Published in Gynecologic oncology (01.04.2005)
Get full text
Journal Article